Canadian Alcohol and Drug Use Monitoring Survey

Detailed Tables

Table 1: Main 2012 CADUMS indicators by sex and by age - Drugs
  Overall Males Females p<0.05
- sex
15-24 25+ p<0.05
- age
  • [95% Confidence Interval]
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high
  • Significant difference between males and females
  • Significant difference between youth age 15-24 and adults age 25+

Table 1 footnotes

Table 1 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 1 footnote 1 referrer

Table 1 footnote 2

Among current user any 5 drugs (cocaine, speed, hallucinogens including salvia, ecstasy, heroin)

Return to table 1 footnote 2 referrer

Table 1 footnote 3

Among current users any drug (cannabis, cocaine, meth/crystal meth, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 1 footnote 3 referrer

Sample size= 11,090 4,386 6,704   687 10,403  
Cannabis use
Cannabis - lifetime 41.5
[39.8-43.3]
47.9
[45.1-50.7]
35.5
[33.4-37.7]
Significant difference between males and females 34.8
[29.5-40.1]
42.8
[41.0-44.6]
Significant difference between youth age 15-24 and adults age 25+
Cannabis - past-year 10.2
[9.1-11.4]
13.7
[11.8-15.6]
7.0
[5.7-8.2]
Significant difference between males and females 20.3
[15.9-24.6]
8.4
[7.3-9.5]
Significant difference between youth age 15-24 and adults age 25+
Age of initiation (years) 18.6
[18.4-18.9]
18.5
[18.1-18.8]
18.8
[18.5-19.1]
  16.1
[15.8-16.4]
19.0
[18.7-19.3]
Significant difference between youth age 15-24 and adults age 25+
Illicit drug use past year
Cocaine/Crack 1.1Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.6]
1.5Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.3]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.1]
 
Speed Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Methamphetamine/Crystal meth Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Hallucinogens 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.3]
1.5Estimate qualified due to high sampling variability; interpret with caution
[0.9-2.2]
Estimate suppressed due to high sampling variability   3.9Estimate qualified due to high sampling variability; interpret with caution
[2.0-5.8]
0.4Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.6]
Significant difference between youth age 15-24 and adults age 25+
Hallucinogens (including salvia) 1.1Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.5]
1.8Estimate qualified due to high sampling variability; interpret with caution
[1.1-2.6]
Estimate suppressed due to high sampling variability   4.8Estimate qualified due to high sampling variability; interpret with caution
[2.6-6.9]
0.4Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.6]
Significant difference between youth age 15-24 and adults age 25+
Ecstasy 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.0]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Salvia Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Heroin Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 10.6
[9.4-11.8]
14.3
[12.3-16.3]
7.1
[5.8-8.3]
Significant difference between males and females 21.3
[16.8-25.8]
8.6
[7.5-9.7]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 2.0
[1.4-2.5]
2.9Estimate qualified due to high sampling variability; interpret with caution
[1.9-3.9]
1.0Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.6]
Significant difference between males and females 6.3Estimate qualified due to high sampling variability; interpret with caution
[3.6-8.9]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.6]
Significant difference between youth age 15-24 and adults age 25+
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 10.6
[9.4-11.8]
14.3
[12.3-16.3]
7.1
[5.8-8.4]
Significant difference between males and females 21.3
[16.8-25.8]
8.6
[7.5-9.7]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 2.0
[1.5-2.6]
3.1Estimate qualified due to high sampling variability; interpret with caution
[2.1-4.1]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.6]
Significant difference between males and females 6.5Estimate qualified due to high sampling variability; interpret with caution
[3.9-9.2]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.8-1.6]
Significant difference between youth age 15-24 and adults age 25+
Any drugc 11.3
[10.1-12.5]
15.2
[13.1-17.2]
7.7
[6.4-9.0]
Significant difference between males and females 22.2
[17.6-26.7]
9.3
[8.1-10.4]
Significant difference between youth age 15-24 and adults age 25+
Lifetime illicit drug use
Cocaine/Crack 7.3
[6.3-8.3]
9.9
[8.2-11.7]
4.7
[3.8-5.7]
Significant difference between males and females 5.5Estimate qualified due to high sampling variability; interpret with caution
[2.8-8.2]
7.6
[6.5-8.7]
 
Speed 4.1
[3.3-4.9]
5.7
[4.3-7.1]
2.5
[1.8-3.2]
Significant difference between males and females 2.4Estimate qualified due to high sampling variability; interpret with caution
[0.9-4.0]
4.4
[3.5-5.3]
Significant difference between youth age 15-24 and adults age 25+
Methamphetamine/Crystal meth 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-0.9]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
  Estimate suppressed due to high sampling variability 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.0]
 
Hallucinogens 12.5
[11.3-13.6]
16.6
[14.5-18.6]
8.6
[7.4-9.8]
Significant difference between males and females 8.7Estimate qualified due to high sampling variability; interpret with caution
[5.7-11.8]
13.2
[11.9-14.4]
Significant difference between youth age 15-24 and adults age 25+
Hallucinogens (including salvia) 12.7
[11.5-13.9]
16.9
[14.8-19.0]
8.7
[7.5-9.9]
Significant difference between males and females 9.4Estimate qualified due to high sampling variability; interpret with caution
[6.3-12.5]
13.3
[12.0-14.6]
Significant difference between youth age 15-24 and adults age 25+
Ecstasy 4.4
[3.6-5.2]
5.6
[4.2-7.1]
3.2
[2.4-4.1]
Significant difference between males and females 7.9Estimate qualified due to high sampling variability; interpret with caution
[5.0-10.9]
3.7
[2.9-4.6]
Significant difference between youth age 15-24 and adults age 25+
Salvia 1.8
[1.2-2.3]
2.9Estimate qualified due to high sampling variability; interpret with caution
[1.9-3.9]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.2]
Significant difference between males and females 6.5Estimate qualified due to high sampling variability; interpret with caution
[3.7-9.3]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
Significant difference between youth age 15-24 and adults age 25+
Heroin 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.1]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.8]
 
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 42.3
[40.6-44.1]
48.8
[46.0-51.6]
36.2
[34.1-38.4]
Significant difference between males and females 35.2
[29.9-40.5]
43.7
[41.8-45.5]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 15.4
[14.1-16.7]
19.7
[17.6-21.9]
11.4
[10.0-12.7]
Significant difference between males and females 12.2
[8.8-15.6]
16.0
[14.7-17.4]
Significant difference between youth age 15-24 and adults age 25+
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 42.3
[40.6-44.1]
48.8
[46.0-51.6]
36.2
[34.1-38.4]
Significant difference between males and females 35.3
[29.9-40.6]
43.7
[41.8-45.5]
Significant difference between youth age 15-24 and adults age 25+
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 15.6
[14.3-16.9]
20.0
[17.8-22.2]
11.4
[10.0-12.8]
Significant difference between males and females 12.5
[9.1-16.0]
16.2
[14.8-17.6]
 
Any drugc 43.2
[41.4-45.0]
49.8
[46.9-52.6]
37.0
[34.9-39.2]
Significant difference between males and females 36.9
[31.4-42.3]
44.4
[42.6-46.3]
Significant difference between youth age 15-24 and adults age 25+
Pharmaceutical use past year
Pain Relievers 16.9
[15.5-18.3]
15.5
[13.4-17.6]
18.2
[16.5-19.9]
  18.0
[13.5-22.6]
16.7
[15.3-18.0]
 
Pain relievers to get high 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.2-1.0]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Pain relievers to get high - among users 3.4Estimate qualified due to high sampling variability; interpret with caution
[1.2-5.6]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of pain relievers (includes to get high) 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.8]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.2]
  Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.7]
 
Abuse of pain relievers (includes to get high) - among users 5.2Estimate qualified due to high sampling variability; interpret with caution
[2.9-7.6]
6.9Estimate qualified due to high sampling variability; interpret with caution
[2.7-11.2]
3.9Estimate qualified due to high sampling variability; interpret with caution
[1.5-6.4]
  Estimate suppressed due to high sampling variability 3.1Estimate qualified due to high sampling variability; interpret with caution
[1.7-4.4]
 
Stimulants 1.5Estimate qualified due to high sampling variability; interpret with caution
[1.0-2.0]
1.9Estimate qualified due to high sampling variability; interpret with caution
[1.0-2.8]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.7]
  4.9Estimate qualified due to high sampling variability; interpret with caution
[2.2-7.6]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
Significant difference between youth age 15-24 and adults age 25+
Stimulants to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Stimulants to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of stimulants 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.2-1.0]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of stimulants  (includes to get high) - among users 40.1Estimate qualified due to high sampling variability; interpret with caution
[22.8-57.4]
32.5Estimate qualified due to high sampling variability; interpret with caution
[12.4-52.6]
52.2Estimate qualified due to high sampling variability; interpret with caution
[26.9-77.4]
  44.0Estimate qualified due to high sampling variability; interpret with caution
[17.0-71.0]
36.1Estimate qualified due to high sampling variability; interpret with caution
[13.1-59.1]
 
Sedatives 10.2
[9.2-11.3]
7.5
[5.9-9.0]
12.8
[11.4-14.2]
Significant difference between males and females 7.5Estimate qualified due to high sampling variability; interpret with caution
[4.4-10.6]
10.7
[9.6-11.8]
 
Sedatives to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Sedatives to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Any pharmaceutical 24.1
[22.5-25.6]
21.3
[18.8-23.7]
26.7
[24.7-28.6]
Significant difference between males and females 24.7
[19.6-29.8]
23.9
[22.4-25.5]
 
Any pharmaceutical to get high 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.3]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.9]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
 
Any pharmaceutical to get high - among users 3.6Estimate qualified due to high sampling variability; interpret with caution
[1.8-5.4]
5.6Estimate qualified due to high sampling variability; interpret with caution
[2.2-9.1]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 1.8Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.9]
 
Abuse of any pharmaceutical (includes to get high) 1.5Estimate qualified due to high sampling variability; interpret with caution
[1.0-2.0]
1.6Estimate qualified due to high sampling variability; interpret with caution
[0.9-2.4]
1.4Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.1]
  4.9Estimate qualified due to high sampling variability; interpret with caution
[2.2-7.5]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
Significant difference between youth age 15-24 and adults age 25+
Abuse of any pharmaceutical (includes to get high) - among users 6.3Estimate qualified due to high sampling variability; interpret with caution
[4.2-8.4]
7.8Estimate qualified due to high sampling variability; interpret with caution
[4.2-11.4]
5.2Estimate qualified due to high sampling variability; interpret with caution
[2.6-7.7]
  19.8Estimate qualified due to high sampling variability; interpret with caution
[10.0-29.5]
3.7Estimate qualified due to high sampling variability; interpret with caution
[2.1-5.2]
Significant difference between youth age 15-24 and adults age 25+
Drug related harms in past yearTable #t1_fnb1 footnote 1
Any drug harm to self - total population 2.0Estimate qualified due to high sampling variability; interpret with caution
[1.4-2.7]
3.0Estimate qualified due to high sampling variability; interpret with caution
[1.8-4.3]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.7]
Significant difference between males and females 5.5Estimate qualified due to high sampling variability; interpret with caution
[2.9-8.2]
1.4Estimate qualified due to high sampling variability; interpret with caution
[0.8-2.0]
Significant difference between youth age 15-24 and adults age 25+
Any drug harm to self among users any 5 drugsTable 1 footnote 2 38.7Estimate qualified due to high sampling variability; interpret with caution
[24.1-53.2]
41.7Estimate qualified due to high sampling variability; interpret with caution
[24.5-58.9]
Estimate suppressed due to high sampling variability   43.0Estimate qualified due to high sampling variability; interpret with caution
[21.1-64.9]
34.3Estimate qualified due to high sampling variability; interpret with caution
[15.8-52.7]
 
Any drug harm to self among users any drugTable 1 footnote 3 16.6
[11.3-21.9]
18.3Estimate qualified due to high sampling variability; interpret with caution
[11.2-25.5]
13.3Estimate qualified due to high sampling variability; interpret with caution
[6.2-20.4]
  24.1Estimate qualified due to high sampling variability; interpret with caution
[13.5-34.7]
13.3Estimate qualified due to high sampling variability; interpret with caution
[7.2-19.3]
 
 
Table 2: Main 2012 CADUMS indicators by province - Drugs
  Canada NL PE NS NB QC ON MB SK AB BC
  • N Sample size
  • Q Estimate qualified due to high sampling variability; interpret with caution
  • S Estimate suppressed due to high sampling variability
  • a Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • b Cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • c Cannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high

Table 2 footnotes

Table 2 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems

Return to table 2 footnote 1 referrer

Table 2 footnote 2

Asked of all users of any drug (cannabis, cocaine, meth/crystal meth, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, abuse of pain killers, abuse of stimulants, sedatives to get high) ; presented among total population

Return to table 2 footnote 2 referrer

Sample size= 11,090 1,008 1,008 1,009 1,009 1,008 1,011 1,009 1,010 1,009 2,009
Cannabis use
Cannabis - lifetime 41.5 38.7 40.9 42.4 36.4 40.6 39.4 38.5 42.5 44.3 48.7
Cannabis - past-year 10.2 11.0 10.6 12.1 8.5 9.0 9.1 13.2 10.2 11.4 13.8
Illicit drug use past year
Cocaine/Crack 1.1Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.4Estimate qualified due to high sampling variability; interpret with caution
Speed Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Methamphetamine/Crystal meth Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Hallucinogens 0.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Ecstasy 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Salvia Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Heroin Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 10.6 11.0 10.6 12.2 8.6 9.5 9.6 13.4 10.6 11.6 13.9
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 2.0 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 2.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 2.9Estimate qualified due to high sampling variability; interpret with caution 2.1Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 2.7Estimate qualified due to high sampling variability; interpret with caution
Any drugc 11.3 11.1 10.8 12.9 9.2 10.0 10.4 14.7 11.1 12.1 14.9
Lifetime illicit drug use
Cocaine/Crack 7.3 6.6Estimate qualified due to high sampling variability; interpret with caution 4.4Estimate qualified due to high sampling variability; interpret with caution 5.0 3.4Estimate qualified due to high sampling variability; interpret with caution 6.3 7.5 6.3Estimate qualified due to high sampling variability; interpret with caution 6.9 7.3 9.9
Speed 4.1 Estimate suppressed due to high sampling variability 2.6Estimate qualified due to high sampling variability; interpret with caution 2.4Estimate qualified due to high sampling variability; interpret with caution 2.7Estimate qualified due to high sampling variability; interpret with caution 5.2 4.3Estimate qualified due to high sampling variability; interpret with caution 2.9Estimate qualified due to high sampling variability; interpret with caution 1.9Estimate qualified due to high sampling variability; interpret with caution 3.1Estimate qualified due to high sampling variability; interpret with caution 3.7
Methamphetamine/Crystal meth 0.7Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.0Estimate qualified due to high sampling variability; interpret with caution
Hallucinogens 12.5 8.2 10.2 10.7 6.9 8.9 12.8 12.4 14.2 14.9 17.4
Ecstasy 4.4 4.9Estimate qualified due to high sampling variability; interpret with caution 3.6Estimate qualified due to high sampling variability; interpret with caution 3.4Estimate qualified due to high sampling variability; interpret with caution 2.2Estimate qualified due to high sampling variability; interpret with caution 3.7Estimate qualified due to high sampling variability; interpret with caution 4.4Estimate qualified due to high sampling variability; interpret with caution 3.4Estimate qualified due to high sampling variability; interpret with caution 4.1Estimate qualified due to high sampling variability; interpret with caution 4.8Estimate qualified due to high sampling variability; interpret with caution 6.3
Salvia 1.8 Estimate suppressed due to high sampling variability 3.1 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 4.1Estimate qualified due to high sampling variability; interpret with caution 2.0Estimate qualified due to high sampling variability; interpret with caution 2.1Estimate qualified due to high sampling variability; interpret with caution
Heroin 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 0.8Estimate qualified due to high sampling variability; interpret with caution
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 42.3 39.0 41.3 43.0 37.3 41.1 40.3 39.7 42.9 45.4 49.5
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 15.4 11.0 12.3 12.9 10.1 13.3 14.7 15.2 15.6 17.6 21.6
Any drugc 43.2 39.4 41.8 44.0 38.7 41.9 41.1 41.1 43.9 46.4 50.6
Drug related harms in past yearTable 2 footnote 1
Any drug harm to self - total populationTable #t2_fnb2 footnote 2 2.0Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 2.5Estimate qualified due to high sampling variability; interpret with caution 2.2Estimate qualified due to high sampling variability; interpret with caution 3.1Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 2.1Estimate qualified due to high sampling variability; interpret with caution
 
Table 3: Prevalence of drug use and harms, total population, CAS 2004, CADUMS 2008 - 2012
  2004
Overall
2008
Overall
2009
Overall
2010
Overall
2011
Overall
2012
Overall
  • [95% Confidence Interval]
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • No comparable estimates.
  • Indicates that the difference between 2008 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2004 is statistically significant.
  • Indicates that the difference between 2010 and 2004 is statistically significant.
  • Indicates that the difference between 2011 and 2004 is statistically significant.
  • Indicates that the difference between 2012 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2008 is statistically significant.
  • Indicates that the difference between 2011 and 2010 is statistically significant.
  • Indicates that the difference between 2012 and 2011 is statistically significant.
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin

Table 3 footnotes

Table 3 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 3 footnote 1 referrer

Table 3 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2012: hallucinogens include salvia.

Return to table 3 footnote 2 referrer

Table 3 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011-2012 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 3 footnote 3 referrer

N= 13,909 16,640 13,082 13,615 10,076 11,090
Cannabis use
Cannabis - lifetime 44.5
[43.0-46.0]
43.9
[42.4-45.4]
42.4
[40.8-44.1]
41.5
[39.9-43.0]
39.4The difference between 2011 and 2004 is statistically significant.
[37.6-41.2]
41.5
[39.8-43.3]
Cannabis - past-year 14.1
[13.1-15.1]
11.4The difference between 2008 and 2004 is statistically significant.
[10.4-12.5]
10.6The difference between 2009 and 2004 is statistically significant.
[9.5-11.8]
10.7The difference between 2010 and 2004 is statistically significant.
[9.8-11.7]
9.1The difference between 2011 and 2004 is statistically significant.The difference between 2011 and 2010 is statistically significant.
[8.0-10.2]
10.2The difference between 2012 and 2004 is statistically significant.
[9.1-11.4]
Cannabis - Age of initiation (years) 18.8
[18.5-19.1]
18.4
[18.2-18.7]
18.7
[18.4-19.0]
18.4
[18.1-18.7]
18.8The difference between 2011 and 2010 is statistically significant.
[18.5-19.1]
18.6
[18.4-18.9]
Illicit drug use past year
Cocaine/Crack 1.9
[1.5-2.3]
1.6
[1.2-2.1]
1.2
[0.8-1.8]
0.7The difference between 2010 and 2004 is statistically significant.
[0.5-0.9]
0.9Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2011 and 2004 is statistically significant.
[0.5-1.3]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.6]
Speed 0.8
[0.6-1.1]
1.1
[0.8-1.5]
0.4
[0.2-0.8]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.6]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
Estimate suppressed due to high sampling variability
Hallucinogens(excluding salvia) 0.7
[0.5-0.9]
No comparable estimates. 0.7
[0.5-1.1]
0.9
[0.6-1.1]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.3]
Hallucinogens (including salvia) No comparable estimates. 2.1
[1.7-2.8]
0.9The difference between 2009 and 2008 is statistically significant.
[0.6-1.4]
1.1
[0.8-1.3]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.5]
Ecstasy 1.1
[0.8-1.5]
1.4
[1.0-1.9]
0.9
[0.6-1.4]
0.7
[0.6-0.9]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.0]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.0]
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 14.5
[13.5-15.6]
No comparable estimates. 11.0The difference between 2009 and 2004 is statistically significant.
[9.9-12.3]
11.0The difference between 2010 and 2004 is statistically significant.
[10.0-12.0]
9.4The difference between 2011 and 2004 is statistically significant.The difference between 2011 and 2010 is statistically significant.
[8.3-10.5]
10.6The difference between 2012 and 2004 is statistically significant.
[9.4-11.8]
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 3.0
[2.6-3.6]
No comparable estimates. 2.0
[1.5-2.6]
1.8The difference between 2010 and 2004 is statistically significant.
[1.5-2.1]
1.7The difference between 2011 and 2004 is statistically significant.
[1.2-2.2]
2.0The difference between 2012 and 2004 is statistically significant.
[1.4-2.5]
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates. 12.1
[11.1-13.2]
11.1
[10.0-12.3]
11.1
[10.1-12.1]
9.4The difference between 2011 and 2010 is statistically significant.
[8.3-10.5]
10.6
[9.4-11.8]
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates. 3.9
[3.3-4.7]
2.1The difference between 2009 and 2008 is statistically significant.
[1.6-2.8]
2.0
[1.6-2.3]
1.9
[1.3-2.4]
2.0
[1.5-2.6]
Pharmaceutical use past year
Pain Relievers No comparable estimates. 21.6
[20.4-22.9]
19.2
[18.0-20.5]
20.6
[19.3-21.8]
16.7The difference between 2011 and 2010 is statistically significant.
[15.4-18.0]
16.9
[15.5-18.3]
Pain relievers to get high No comparable estimates. 0.3
[0.2-0.6]
0.4
[0.2-0.9]
0.2Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.4]
Estimate suppressed due to high sampling variability 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.2-1.0]
Pain relievers to get high - among users No comparable estimates. 1.5
[0.9-2.6]
2.3
[1.1-4.5]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.7]
Estimate suppressed due to high sampling variability 3.4Estimate qualified due to high sampling variability; interpret with caution
[1.2-5.6]
Abuse of pain relievers (includes to get high) No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
Abuse of pain relievers (includes to get high) - among users No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 5.2Estimate qualified due to high sampling variability; interpret with caution
[2.9-7.6]
Stimulants No comparable estimates. 1.1
[0.8-1.5]
1.0
[0.7-1.4]
1.0
[0.8-1.3]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.2]
1.5Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant.
[1.0-2.0]
Stimulants to get high No comparable estimates. 0.3
[0.1-0.6]
0.1
[0.0-0.3]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants to get high - among users No comparable estimates. 25.5
[12.3-45.5]
9.4
[2.6-28.6]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
Abuse of stimulants  (includes to get high) - among users No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. 27.4Estimate qualified due to high sampling variability; interpret with caution
[10.5-44.3]
40.1Estimate qualified due to high sampling variability; interpret with caution
[22.8-57.4]
Sedatives No comparable estimates. 10.7
[9.8-11.6]
9.1
[8.2-10.0]
8.7
[7.8-9.6]
9.1
[8.1-10.0]
10.2
[9.2-11.3]
Sedatives to get high No comparable estimates. 0.2
[0.0-0.5]
0.2
[0.1-0.4]
0.05Estimate qualified due to high sampling variability; interpret with caution
[0.02-0.08]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Sedatives to get high - among users No comparable estimates. 1.4Estimate qualified due to high sampling variability; interpret with caution
[0.5-4.3]
1.7
[0.6-4.7]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.9]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical No comparable estimates. 28.4
[27.0-29.7]
25.0The difference between 2009 and 2008 is statistically significant.
[23.7-26.4]
26.0
[24.6-27.3]
22.9The difference between 2011 and 2010 is statistically significant.
[21.5-24.4]
24.1
[22.5-25.6]
Any pharmaceutical to get high No comparable estimates. 0.6
[0.3-0.9]
0.6
[0.3-1.0]
0.3Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.4]
0.3Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.5]
0.9Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant.
[0.4-1.3]
Any pharmaceutical to get high - among users No comparable estimates. 2.0
[1.2-3.2]
2.3
[1.2-4.1]
1.0Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.6]
1.5Estimate qualified due to high sampling variability; interpret with caution
[0.6-2.4]
3.6Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant.
[1.8-5.4]
Abuse of any pharmaceutical (includes to get high) No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.1]
1.5Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant.
[1.0-2.0]
Abuse of any pharmaceutical (includes to get high) - among users No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. 3.2Estimate qualified due to high sampling variability; interpret with caution
[1.6-4.8]
6.3The difference between 2012 and 2011 is statistically significant.
[4.2-8.4]
Drug related harms in past yearTable 3 footnote 1
Any drug harm to self - total population 2.8
[2.4-3.3]
2.7
[2.1-3.3]
No comparable estimates. 2.1
[1.7-2.6]
1.8The difference between 2011 and 2004 is statistically significant.
[1.3-2.3]
2.0Estimate qualified due to high sampling variability; interpret with caution
[1.4-2.7]
Any drug harm to self among users any 5 drugsTable 3 footnote 2 36.7
[29.1-45.1]
37.5
[28.9-47.0]
No comparable estimates. 36.4
[27.7-45.0]
41.6Estimate qualified due to high sampling variability; interpret with caution
[26.9-56.3]
38.7Estimate qualified due to high sampling variability; interpret with caution
[24.1-53.2]
Any drug harm to self among users any drugTable 3 footnote 3 17.5
[14.8-20.5]
21.7
[17.6-26.3]
No comparable estimates. 17.0
[13.5-20.5]
17.6
[13.0-22.1]
16.6
[11.3-21.9]
 
Table 4: Prevalence of drug use and harms, by age group, CAS 2004 and CADUMS 2008 - 2012
  CAS 2004
15-24
CADUMS 2008
15-24
CADUMS 2009
15-24
CADUMS 2010
15-24
CADUMS 2011
15-24
CADUMS 2012
15-24
CAS 2004
25+
CADUMS 2008
25+
CADUMS 2009
25+
CADUMS 2010
25+
CADUMS 2011
25+
CADUMS 2012
25+
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • No comparable estimates.
  • Indicates that the difference between 2008 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2004 is statistically significant.
  • Indicates that the difference between 2010 and 2004 is statistically significant.
  • Indicates that the difference between 2011 and 2004 is statistically significant.
  • Indicates that the difference between 2012 and 2004 is statistically significant.
  • Indicates that the difference between 2009 and 2008 is statistically significant.
  • Indicates that the difference between 2011 and 2010 is statistically significant.
  • Indicates that the difference between 2012 and 2011 is statistically significant.
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin

Table 4 footnotes

Table 4 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to Table 4 footnote 1 referrer

Table 4 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2012: hallucinogens include salvia.

Return to Table 4 footnote 2 referrer

Table 4 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011-2012 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high).

Return to Table 4 footnote 3 referrer

Sample size= 2,085 1,443 955 3,989 671 687 11,519 15,197 12,079 9,626 9,405 10,403
Cannabis use
Cannabis - lifetime 61.4 52.9The difference between 2008 and 2004 is statistically significant. 42.9The difference between 2009 and 2004 is statistically significant. 41.7The difference between 2010 and 2004 is statistically significant. 34.0The difference between 2011 and 2004 is statistically significant.The difference between 2011 and 2010 is statistically significant. 34.8The difference between 2012 and 2004 is statistically significant. 41.8 42.1 42.3 41.4 40.4 42.8
Cannabis - past year 37.0 32.7 26.3The difference between 2009 and 2004 is statistically significant. 25.1The difference between 2010 and 2004 is statistically significant. 21.6The difference between 2011 and 2004 is statistically significant.
20.3The difference between 2012 and 2004 is statistically significant. 10.0 7.3The difference between 2008 and 2004 is statistically significant. 7.6The difference between 2009 and 2004 is statistically significant. 7.9 6.7The difference between 2011 and 2004 is statistically significant.
8.4The difference between 2012 and 2011 is statistically significant.
Age of initiation (Years) 15.6 15.5 15.6 15.7 15.6
16.1The difference between 2012 and 2011 is statistically significant. 19.7 19.2 19.3 18.9The difference between 2010 and 2004 is statistically significant. 19.3 19.0
Illicit drug use past year
Cocaine/Crack 5.5 5.9 3.0Estimate qualified due to high sampling variability; interpret with caution 2.7The difference between 2010 and 2004 is statistically significant. Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.2 0.8 0.9 0.3Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2010 and 2004 is statistically significant. 0.7Estimate qualified due to high sampling variability; interpret with caution 0.7Estimate qualified due to high sampling variability; interpret with caution
Speed 3.9 3.7 Estimate suppressed due to high sampling variability 1.9Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2010 and 2004 is statistically significant. Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 0.2 0.6 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Hallucinogens (excl. salvia) 3.5 No comparable estimates 3.2Estimate qualified due to high sampling variability; interpret with caution 3.4 2.0Estimate qualified due to high sampling variability; interpret with caution 3.9Estimate qualified due to high sampling variability; interpret with caution 0.1 No comparable estimates 0.3 0.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution
Hallucinogens (incl. salvia) No comparable estimates 10.2 4.4The difference between 2009 and 2008 is statistically significant. 4.6 3.4Estimate qualified due to high sampling variability; interpret with caution 4.8Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 0.6 0.3 0.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution
Ecstasy 4.4 6.5 3.6 3.8 2.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 0.5 0.4 0.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 37.9 No comparable estimates 27.3The difference between 2009 and 2004 is statistically significant. 25.9The difference between 2010 and 2004 is statistically significant. 21.9The difference between 2011 and 2004 is statistically significant. 21.3The difference between 2012 and 2004 is statistically significant. 10.3 No comparable estimates 7.9The difference between 2009 and 2004 is statistically significant. 8.1The difference between 2010 and 2004 is statistically significant. 6.9The difference between 2011 and 2004 is statistically significant. 8.6The difference between 2012 and 2011 is statistically significant.
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 11.3 No comparable estimates 5.5The difference between 2009 and 2004 is statistically significant. 7.0The difference between 2010 and 2004 is statistically significant. 4.8Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2011 and 2004 is statistically significant. 6.3Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2004 is statistically significant. 1.5 No comparable estimates 1.3 0.8Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution 1.2Estimate qualified due to high sampling variability; interpret with caution
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 34.0 27.5 26.1 21.9 21.3 No comparable estimates 7.9 7.9 8.2 6.9 8.6The difference between 2012 and 2011 is statistically significant.
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 15.4 6.3The difference between 2009 and 2008 is statistically significant. 7.9 5.8Estimate qualified due to high sampling variability; interpret with caution 6.5Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 1.7 1.3 0.8Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution 1.2Estimate qualified due to high sampling variability; interpret with caution
Pharmaceutical use past year
Pain Relievers No comparable estimates 17.7 14.6 18.2 14.3 18.0 No comparable estimates 22.4 20.2 21.0 17.1The difference between 2011 and 2010 is statistically significant. 16.7
Pain Relievers to get high No comparable estimates 0.9Estimate qualified due to high sampling variability; interpret with caution 1.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.2 0.3 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Pain Relievers to get high - among users No comparable estimates 4.9 8.5 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 1.0 1.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates 0.2Estimate qualified due to high sampling variability; interpret with caution 0.5Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant.
Abuse of pain relievers (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates 1.3Estimate qualified due to high sampling variability; interpret with caution 3.1Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant.
Stimulants No comparable estimates 3.1 2.7Estimate qualified due to high sampling variability; interpret with caution 3.2 2.4Estimate qualified due to high sampling variability; interpret with caution 4.9Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 0.7 0.6 0.6Estimate qualified due to high sampling variability; interpret with caution 0.6Estimate qualified due to high sampling variability; interpret with caution 0.9Estimate qualified due to high sampling variability; interpret with caution
Stimulants to get high No comparable estimates 1.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.1 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants to get high - among users No comparable estimates 38.3Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 14.7Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability 44.0Estimate qualified due to high sampling variability; interpret with caution No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability 36.1Estimate qualified due to high sampling variability; interpret with caution
Sedatives No comparable estimates 5.5 4.0 3.5 4.0Estimate qualified due to high sampling variability; interpret with caution 7.5Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 11.7 10.1 9.7 10.1 10.7
Sedative to get high No comparable estimates 0.8Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Sedatives to get high - among users No comparable estimates 14.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical No comparable estimates 22.3 18.2 22.1 17.6 24.7The difference between 2012 and 2011 is statistically significant. No comparable estimates 29.5 26.3The difference between 2009 and 2008 is statistically significant. 26.7 23.9The difference between 2011 and 2010 is statistically significant. 23.9
Any pharmaceutical to get high No comparable estimates 2.1Estimate qualified due to high sampling variability; interpret with caution 1.7Estimate qualified due to high sampling variability; interpret with caution 0.8Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.3 0.3 Estimate suppressed due to high sampling variability 0.2Estimate qualified due to high sampling variability; interpret with caution 0.4Estimate qualified due to high sampling variability; interpret with caution
Any pharmaceutical to get high - among users No comparable estimates 9.4 9.5 3.8 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.9 1.3 Estimate suppressed due to high sampling variability 0.9Estimate qualified due to high sampling variability; interpret with caution 1.8Estimate qualified due to high sampling variability; interpret with caution
Abuse of any pharmaceutical (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability 4.9Estimate qualified due to high sampling variability; interpret with caution No comparable estimates No comparable estimates No comparable estimates No comparable estimates 0.5Estimate qualified due to high sampling variability; interpret with caution 0.9Estimate qualified due to high sampling variability; interpret with caution
Abuse of any pharmaceutical (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability 19.8Estimate qualified due to high sampling variability; interpret with caution No comparable estimates No comparable estimates No comparable estimates No comparable estimates 1.9Estimate qualified due to high sampling variability; interpret with caution 3.7Estimate qualified due to high sampling variability; interpret with caution
Drug related harms in past yearTable 4 footnote 1
Any drug harm to self - of total population 9.5 10.8 No comparable estimates 6.9 5.8Estimate qualified due to high sampling variability; interpret with caution 5.5Estimate qualified due to high sampling variability; interpret with caution 1.6 1.1 No comparable estimates 1.2Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution 1.4Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any 5 drugsTable 4 footnote 2 42.1 42.0 No comparable estimates 41.6 45.0Estimate qualified due to high sampling variability; interpret with caution 43.0Estimate qualified due to high sampling variability; interpret with caution 28.7 29.5 No comparable estimates 26.6Estimate qualified due to high sampling variability; interpret with caution 38.1Estimate qualified due to high sampling variability; interpret with caution 34.3Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any drugTable 4 footnote 3 24.0 31.5 No comparable estimates 24.7 23.1Estimate qualified due to high sampling variability; interpret with caution 24.1Estimate qualified due to high sampling variability; interpret with caution 12.7 13.5 No comparable estimates 12.2Estimate qualified due to high sampling variability; interpret with caution 14.2Estimate qualified due to high sampling variability; interpret with caution 13.3Estimate qualified due to high sampling variability; interpret with caution
 
Table 5: Prevalence of drug use and harms, by sex, CAS 2004, CADUMS 2008 - 2012
  CAS 2004 Males CADUMS 2008 Males CADUMS 2009 Males CADUMS 2010 Males CADUMS 2011 Males CADUMS 2012 Males CAS 2004 Females CADUMS 2008 Females CADUMS 2009 Females CADUMS 2010 Females CADUMS 2011 Females CADUMS 2012 Females
  • Sample size
  • Estimate qualified due to high sampling variability; interpret with caution
  • Estimate suppressed due to high sampling variability
  • No comparable estimates.
  • Indicates the difference between 2008 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2010 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
  • Indicates the difference between 2012 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2008 is statistically significant.
  • Indicates the difference between 2010 and 2009 is statistically significant.
  • Indicates the difference between 2011 and 2010 is statistically significant.
  • Indicates the difference between 2012 and 2011 is statistically significant.
  • Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  • Cocaine/crack, speed, ecstasy, hallucinogens, heroin

Table 5 footnotes

Table 5 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 5 footnote 1 referrer

Table 5 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2012: hallucinogens include salvia.

Return to table 5 footnote 2 referrer

Table 5 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011-2012 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 5 footnote 3 referrer

Sample size= 5,721 6,583 5,260 5,980 4,247 4,386 8,188 10,057 7,822 7,635 5,829 6,704
Cannabis use
Cannabis - lifetime 50.1 49.3 48.0 48.8 45.5 47.9 39.2 38.8 37.2 34.5The difference between 2010 and 2004 is statistically significant. 33.6The difference between 2011 and 2004 is statistically significant. 35.5
Cannabis - past-year 18.2 14.4The difference between 2008 and 2004 is statistically significant. 14.2The difference between 2009 and 2004 is statistically significant. 14.6The difference between 2010 and 2004 is statistically significant. 12.2The difference between 2011 and 2004 is statistically significant. 13.7The difference between 2012 and 2004 is statistically significant. 10.2 8.6 7.2The difference between 2009 and 2004 is statistically significant. 7.1The difference between 2010 and 2004 is statistically significant. 6.2The difference between 2011 and 2004 is statistically significant. 7.0The difference between 2012 and 2004 is statistically significant.
Cannabis - Age of initiation (years) 18.8 18.5 18.7 18.4 18.6 18.5 18.7 18.4 18.7 18.4 19.0The difference between 2011 and 2010 is statistically significant. 18.8
Illicit drug use past year
Cocaine/Crack 2.7 2.3 1.5 1.0Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2010 and 2004 is statistically significant. 1.4Estimate qualified due to high sampling variability; interpret with caution 1.5Estimate qualified due to high sampling variability; interpret with caution 1.1 0.9 0.9 0.4Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2010 and 2004 is statistically significant. Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Speed 1.0 1.3 Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 0.7 0.8 Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Hallucinogens (excl. salvia) 1.0 No comparable estimates. 0.7 1.3Estimate qualified due to high sampling variability; interpret with caution 0.9Estimate qualified due to high sampling variability; interpret with caution 1.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability No comparable estimates. 0.8 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Hallucinogens (incl. salvia) No comparable estimates. 3.3 1.1The difference between 2009 and 2008 is statistically significant. 1.6 1.3Estimate qualified due to high sampling variability; interpret with caution 1.8Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. 1.1 0.8 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Ecstasy 1.5 1.7 1.1 0.9Estimate qualified due to high sampling variability; interpret with caution 0.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 0.7 1.1 0.7 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 18.7 No comparable estimates. 14.7The difference between 2009 and 2004 is statistically significant. 15.0The difference between 2010 and 2004 is statistically significant. 12.4The difference between 2011 and 2004 is statistically significant.The difference between 2011 and 2010 is statistically significant. 14.3The difference between 2012 and 2004 is statistically significant. 10.6 No comparable estimates. 7.6The difference between 2009 and 2004 is statistically significant. 7.3The difference between 2010 and 2004 is statistically significant. 6.5The difference between 2011 and 2004 is statistically significant. 7.1The difference between 2012 and 2004 is statistically significant.
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 4.3 No comparable estimates. 2.5 2.5The difference between 2010 and 2004 is statistically significant. 2.4Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2011 and 2004 is statistically significant. 2.9Estimate qualified due to high sampling variability; interpret with caution 1.8 No comparable estimates. 1.5 1.2 1.0Estimate qualified due to high sampling variability; interpret with caution 1.0Estimate qualified due to high sampling variability; interpret with caution
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates. 15.3 14.8 15.1 12.5The difference between 2011 and 2010 is statistically significant. 14.3 No comparable estimates. 9.1 7.6 7.3 6.5 7.1
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates. 5.5 2.8The difference between 2009 and 2008 is statistically significant. 2.8 2.7Estimate qualified due to high sampling variability; interpret with caution 3.1Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. 2.4 1.5 1.3 1.1Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution
Pharmaceutical use past year
Pain Relievers No comparable estimates. 18.9 18.3 20.9 15.8The difference between 2011 and 2010 is statistically significant. 15.5 No comparable estimates. 24.2 20.2The difference between 2009 and 2008 is statistically significant. 20.3 17.4The difference between 2011 and 2010 is statistically significant. 18.2
Pain relievers to get high No comparable estimates. 0.3Estimate qualified due to high sampling variability; interpret with caution 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates. 0.4Estimate qualified due to high sampling variability; interpret with caution 0.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Pain relievers to get high - among users No comparable estimates. 1.5 2.8 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates. 1.5 1.8 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 1.1Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 0.7Estimate qualified due to high sampling variability; interpret with caution
Abuse of pain relievers (includes to get high) - among users No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 6.9Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 3.9Estimate qualified due to high sampling variability; interpret with caution
Stimulants No comparable estimates. 1.0 0.6 1.2Estimate qualified due to high sampling variability; interpret with cautionIndicates the difference between 2010 and 2009 is statistically significant. 1.2Estimate qualified due to high sampling variability; interpret with caution 1.9Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. 1.2 1.2 0.9 0.5Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution
Stimulants to get high No comparable estimates. 0.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates. 0.3Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants to get high - among users No comparable estimates. 22.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates. 27.8 Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 0.6Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) - among users No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 32.5Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 52.2Estimate qualified due to high sampling variability; interpret with caution
Sedatives No comparable estimates. 8.0 7.0 6.4 5.9 7.5 No comparable estimates. 13.2 11.1 10.8 12.0 12.8
Sedatives to get high No comparable estimates. 0.1Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates. 0.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Sedatives to get high - among users No comparable estimates. Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates. 1.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical No comparable estimates. 24.4 22.3 24.7 20.2The difference between 2011 and 2010 is statistically significant. 21.3 No comparable estimates. 32.1 27.6The difference between 2009 and 2008 is statistically significant. 27.1 25.5 26.7
Any pharmaceutical to get high No comparable estimates. 0.5Estimate qualified due to high sampling variability; interpret with caution 0.7 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.2Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. 0.6 0.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical to get high - among users No comparable estimates. 2.1 3.3 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 5.6Estimate qualified due to high sampling variability; interpret with caution No comparable estimates. 1.9 1.5 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of any pharmaceutical (includes to get high) No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. 0.6Estimate qualified due to high sampling variability; interpret with caution 1.6Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant. No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 1.4Estimate qualified due to high sampling variability; interpret with caution
Abuse of any pharmaceutical (includes to get high) - among users No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. 3.1Estimate qualified due to high sampling variability; interpret with caution 7.8Estimate qualified due to high sampling variability; interpret with cautionThe difference between 2012 and 2011 is statistically significant. No comparable estimates. No comparable estimates. No comparable estimates. No comparable estimates. Estimate suppressed due to high sampling variability 5.2Estimate qualified due to high sampling variability; interpret with caution
Drug related harms in past yearTable 5 footnote 1
Any drug harm to self - total population 3.8 3.5 No comparable estimates. 2.7 2.3Estimate qualified due to high sampling variability; interpret with caution 3.0Estimate qualified due to high sampling variability; interpret with caution 1.9 1.8 No comparable estimates. 1.7 1.3Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any 5 drugsTable 5 footnote 2 37.2 36.1 No comparable estimates. 35.8 38.2Estimate qualified due to high sampling variability; interpret with caution 41.7Estimate qualified due to high sampling variability; interpret with caution 35.7 40.7 No comparable estimates. 37.5Estimate qualified due to high sampling variability; interpret with caution 49.7Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Any drug harm to self among users any drugTable 5 footnote 3 18.4 22.8 No comparable estimates. 15.8 16.6Estimate qualified due to high sampling variability; interpret with caution 18.3Estimate qualified due to high sampling variability; interpret with caution 16.0 19.8 No comparable estimates. 19.2 19.3Estimate qualified due to high sampling variability; interpret with caution 13.3Estimate qualified due to high sampling variability; interpret with caution
 
Table 6: Main 2012 CADUMS indicators by sex and by age - Alcohol
  Overall Males Females p<0.05
- sex
15-24 25+ p<0.05
- age
  • [95% Confidence Interval]
  • Sample size
  • Significant difference between males and females
  • Significant difference between youth age 15-24 and adults age 25+

Table 6 footnotes

Table 6 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 6 footnote 1 referrer

Sample size= 11,090 4,386 6,704   687 10,403  
Alcohol
Lifetime Use 91.0
[89.9-92.2]
92.9
[91.2-94.5]
89.3
[87.6-90.9]
Significant difference between males and females 79.5
[74.7-84.3]
93.1
[92.1-94.1]
Significant difference between youth age 15-24 and adults age 25+
Past 12 month Use 78.4
[77.0-79.9]
82.7
[80.6-84.8]
74.4
[72.4-76.4]
Significant difference between males and females 70.0
[64.5-75.5]
80.0
[78.6-81.4]
Significant difference between youth age 15-24 and adults age 25+
Past 30 days Use 63.3
[61.6-65.1]
69.8
[67.1-72.4]
57.2
[55.0-59.5]
Significant difference between males and females 49.9
[44.1-55.7]
65.8
[64.1-67.6]
Significant difference between youth age 15-24 and adults age 25+
Age of initiation (years) 18.3
[18.1-18.5]
17.3
[17.1-17.6]
19.2
[19.0-19.5]
Significant difference between males and females 16.2
[16.0-16.5]
18.6
[18.4-18.8]
Significant difference between youth age 15-24 and adults age 25+
Exceeding low-risk drinking guidelines (LRDG)Table 6 footnote 1
Exceeds LRDG chronic 14.4
[13.1-15.7]
17.3
[15.1-19.5]
11.8
[10.2-13.3]
Significant difference between males and females 17.0
[12.5-21.5]
13.9
[12.6-15.2]
 
Exceeds LRDG acute 9.9
[8.8-11.0]
12.9
[11.1-14.8]
7.2
[6.0-8.4]
Significant difference between males and females 12.5
[8.5-16.4]
9.4
[8.4-10.5]
 
Exceeds LRDG chronic - among drinkers 18.6
[16.9-20.2]
21.2
[18.5-23.8]
15.9
[13.9-17.9]
Significant difference between males and females 24.4
[18.3-30.6]
17.6
[15.9-19.2]
Significant difference between youth age 15-24 and adults age 25+
Exceeds LRDG acute - among drinkers 12.8
[11.4-14.2]
15.8
[13.5-18.0]
9.7
[8.1-11.4]
Significant difference between males and females 17.9
[12.4-23.3]
11.9
[10.6-13.3]
Significant difference between youth age 15-24 and adults age 25+
 
Table 7: Main 2012 CADUMS indicators by province - Alcohol
  Canada NL PE NS NB QC ON MB SK AB BC

Sample size

Table 7 footnotes

Table 7 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 7 footnote 1 referrer

Sample size= 11,090 1,008 1,008 1,009 1,009 1,008 1,011 1,009 1,010 1,009 2,009
Alcohol
Lifetime Use 91.0 91.2 89.6 90.8 92.0 92.8 90.1 92.8 93.6 88.3 91.4
Past 12 month Use 78.4 76.0 74.0 72.3 73.8 82.1 77.7 79.5 78.5 76.2 78.1
Past 30 days Use 63.3 58.5 56.8 53.1 56.7 68.0 63.1 62.8 62.7 59.4 62.9
Exceeding low-risk drinking guidelines (LRDG)Table 7 footnote 1
Exceeds LRDG chronic 14.4 16.1 12.3 13.0 15.0 16.1 14.5 13.6 14.6 11.9 13.5
Exceeds LRDG acute 9.9 13.4 9.2 10.1 10.4 10.4 9.9 8.6 11.3 8.8 9.9
Exceeds LRDG chronic - among drinkers 18.6 21.5 16.9 18.3 20.5 19.9 18.8 17.3 18.8 15.8 17.6
Exceeds LRDG acute - among drinkers 12.8 17.9 12.7 14.2 14.2 12.8 12.8 10.9 14.5 11.6 12.8
 
Table 8: Prevalence of alcohol use and exceeding LRDG, total population, CAS 2004, CADUMS 2008 - 2012
  2004 Overall 2008 Overall 2009 Overall 2010 Overall 2011 Overall 2012 Overall
  • [95% Confidence Interval]
  • Sample size
  • Indicates the difference between 2008 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2010 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.

Table 8 footnotes

Table 8 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 8 footnote 1 referrer

Sample size= 13,909 16,640 13,082 13,615 10,076 11,090
Alcohol
Lifetime Use 92.8
[91.6-93.9]
90.2The difference between 2008 and 2004 is statistically significant.
[89.2-91.1]
88.6The difference between 2009 and 2004 is statistically significant.
[87.5-89.6]
88.9The difference between 2010 and 2004 is statistically significant.
[87.9-89.9]
89.7The difference between 2011 and 2004 is statistically significant.
[88.4-91.0]
91.0
[89.9-92.2]
Past 12 month Use 79.3
[78.1-80.5]
77.3
[76.0-78.6]
76.5The difference between 2009 and 2004 is statistically significant.
[75.1-77.8]
77.0The difference between 2010 and 2004 is statistically significant.
[75.6-78.3]
78.0
[76.4-79.5]
78.4
[77.0-79.9]
Age of initiation (years) 17.9
[17.8-18.1]
18.0
[17.9-18.2]
18.0
[17.9-18.2]
18.2
[18.0-18.3]
18.1
[18.0-18.3]
18.3
[18.1-18.5]
Exceeding low-risk drinking guidelinesTable 8 footnote 1
Exceeds LRDG chronic 14.3
[13.2-15.3]
15.0
[13.9-16.2]
14.5
[13.3-15.7]
14.5
[13.4-15.6]
14.4
[13.1-15.8]
14.4
[13.1-15.7]
Exceeds LRDG acute 10.2
[9.2-11.1]
10.9
[9.8-11.9]
11.7
[10.5-12.9]
10.5
[9.5-11.5]
10.1
[8.9-11.2]
9.9
[8.8-11.0]
Exceeds LRDG chronic - among drinkers 18.0
[16.7-19.4]
19.8
[18.3-21.2]
19.1
[17.6-20.7]
19.1
[17.6-20.5]
18.7
[17.0-20.4]
18.6
[16.9-20.2]
Exceeds LRDG acute - among drinkers 12.9
[11.7-14.0]
14.3
[12.9-15.6]
15.5
[14.0-17.0]
13.8
[12.6-15.1]
13.1
[11.6-14.5]
12.8
[11.4-14.2]
 
Table 9: Prevalence of alcohol use and Exceeding LRDG, by age, CAS 2004, CADUMS 2008 - 2012
  CAS
2004
15-24
CADUMS 2008
15-24
CADUMS 2009
15-24
CADUMS 2010
15-24
CADUMS 2011
15-24
CADUMS 2012
15-24
CAS 2004
25+
CADUMS 2008
25+
CADUMS 2009
25+
CADUMS 2010
25+
CADUMS 2011
25+
CADUMS 2012
25+
  • Sample size
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
  • Indicates the difference between 2012 and 2004 is statistically significant.

Table 9 footnotes

Table 9 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 9 footnote 1 referrer

Sample size= 2,085 1,443 955 3,989 671 687 11,519 15,197 12,079 9,626 9,405 10,403
Alcohol
Lifetime Use 90.0 83.5 81.8 79.0 77.9The difference between 2011 and 2004 is statistically significant. 79.5The difference between 2012 and 2004 is statistically significant. 93.6 91.4 89.9The difference between 2009 and 2004 is statistically significant. 90.9 92.0 93.1
Past 12 month Use 82.9 78.4 75.5The difference between 2009 and 2004 is statistically significant. 71.5 70.8The difference between 2011 and 2004 is statistically significant. 70.0The difference between 2012 and 2004 is statistically significant. 78.8 77.1 76.7 78.0 79.3 80.0
Age of initiation (years) 15.6 15.6 15.9 15.9 16.0 16.2The difference between 2012 and 2004 is statistically significant. 18.3 18.5 18.4 18.6 18.5 18.6
Exceeding low-risk drinking guidelinesTable 9 footnote 1
Exceeds LRDG chronic 18.6 22.8 19.8 18.4 14.9 17.0 9.8 13.6 13.4 13.8 14.4 13.9The difference between 2012 and 2004 is statistically significant.
Exceeds LRDG acute 13.7 18.4 17.4 15.1 12.8 12.5 6.4 9.4 10.6 9.6 9.5 9.4The difference between 2012 and 2004 is statistically significant.
Exceeds LRDG chronic - among drinkers 22.4 29.5 26.4 25.9 21.1 24.4 13.0 17.9 17.7 17.8 18.3 17.6The difference between 2012 and 2004 is statistically significant.
Exceeds LRDG acute - among drinkers 16.5 23.8 23.2 21.3 18.1 17.9 8.6 12.4 13.9 12.5 12.2 11.9The difference between 2012 and 2004 is statistically significant.
 
Table 10: Prevalence of alcohol use and exceeding LRDG, by sex, CAS 2004, CADUMS 2008 - 2012
  CAS
2004
Males
CADUMS 2008
Males
CADUMS 2009
Males
CADUMS 2010
Males
CADUMS 2011
Males
CADUMS 2012
Males
CAS 2004
Females
CADUMS 2008
Females
CADUMS 2009
Females
CADUMS 2010
Females
CADUMS 2011
Females
CADUMS 2012
Females
  • Sample size
  • Indicates the difference between 2008 and 2004 is statistically significant.
  • Indicates the difference between 2009 and 2004 is statistically significant.
  • Indicates the difference between 2010 and 2004 is statistically significant.
  • Indicates the difference between 2011 and 2004 is statistically significant.
  • Indicates the difference between 2012 and 2011 is statistically significant.

Table 10 footnotes

Table 10 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 10 footnote 1 referrer

Sample size= 5,721 6,583 5,260 5,980 4,247 4,386 8,188 10,057 7,822 7,635 5,829 6,704
Alcohol
Lifetime Use 94.6 93.0 91.0The difference between 2009 and 2004 is statistically significant. 91.3The difference between 2010 and 2004 is statistically significant. 92.9 92.9 91.1 87.5The difference between 2008 and 2004 is statistically significant. 86.3The difference between 2009 and 2004 is statistically significant. 86.7The difference between 2010 and 2004 is statistically significant. 86.8The difference between 2011 and 2004 is statistically significant. 89.3
Past 12 month Use 82.0 81.4 80.2 80.2 81.9 82.7 76.8 73.5 73.0The difference between 2009 and 2004 is statistically significant. 73.9 74.3 74.4
Age of initiation (years) 17.1 17.4 17.3 17.5 17.5 17.3 18.7 18.6 18.7 18.8 18.8 19.2The difference between 2012 and 2011 is statistically significant.
Exceeding low-risk drinking guidelinesTable #t10_fnb10 footnote 1
Exceeds LRDG chronic 17.2 18.9 17.6 17.2 18.1 17.3 11.5 11.6 11.6 12.1 11.1 11.8
Exceeds LRDG acute 13.0 14.8 15.2 13.6 13.5 12.9 7.5 7.4 8.5 7.7 7.0 7.2
Exceeds LRDG chronic - among drinkers 21.1 23.6 22.2 21.8 22.3 21.2 15.0 16.0 22.2 16.4 15.0 15.9
Exceeds LRDG acute - among drinkers 15.9 18.5 19.1 17.1 16.6 15.8 9.8 10.1 11.8 10.5 9.5 9.7
 

Page details

Date modified: